Adjuvant Therapy With Capecitabine Postpones Recurrence of Hepatocellular Carcinoma After Curative Resection: A Randomized Controlled Trial |
| |
| Authors: | Yong Xia Yinghe Qiu Jun Li Lehua Shi Kui Wang Tao Xi Feng Shen Zhenlin Yan Mengchao Wu |
| |
| Affiliation: | (1) The First Department of Comprehensive Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China; |
| |
| Abstract: | ![]()
Background Postoperative recurrence of hepatocellular carcinoma (HCC) is a major problem after surgical resection. To date, adjuvant chemotherapy or other adjuvant modalities have not been proven effective in preventing or delaying recurrence. The aim of this prospective randomized study was to evaluate the effectiveness of capecitabine as a postoperative adjuvant regimen in inhibiting the recurrence of HCC. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
